Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rujuta Gadgil"'
Autor:
Lee S. Schwartzberg, MD, Gerald Li, PhD, Khaled Tolba, MD, Ariel B. Bourla, MD, PhD, Katja Schulze, PhD, Rujuta Gadgil, MS, Alexander Fine, PhD, Katherine T. Lofgren, PhD, Ryon P. Graf, PhD, Geoffrey R. Oxnard, MD, Davey Daniel, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 9, Pp 100386- (2022)
Introduction: Whereas tumor biopsy is the reference standard for genomic profiling of advanced NSCLC, there are now multiple assays approved by the Food and Drug Administration for liquid biopsy testing of circulating tumor DNA. Here, we study the in
Externí odkaz:
https://doaj.org/article/6ee120b19f7d45749c83a4e3900b99b2
Autor:
Patrick W. McGarrah, Christoph R. Becker, Rujuta Gadgil, Jennifer A. Chan, Pamela L. Kunz, Nitya Raj, Emily K. Bergsland, David Chan, Alia Thawer, Virginia Kelly, Linda Wu, Diane Lauren Reidy, Kathleen Hornbacker, Thorvardur R. Halfdanarson, Simron Singh, Julia Whitman
Publikováno v:
Oncologist
Background Grade 3 gastroenteropancreatic neuroendocrine neoplasms (G3 GEPNENs) are often aggressive, and the optimal treatment is unclear for this subgroup of neuroendocrine neoplasms (NENs). Temozolomide (TEM)-based regimens have been increasingly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb257998389bdbbe48a2faa472e98fd5
https://doi.org/10.1002/onco.13923
https://doi.org/10.1002/onco.13923
Autor:
Nadia A. Ayoub, Cheryl Y. Hayashi, Jessica E. Garb, Rujuta Gadgil, Thomas H. Clarke, Robert A. Haney, Ryan Fitzpatrick
Publikováno v:
Genome Biology and Evolution
Gene duplication and positive selection can be important determinants of the evolution of venom, a protein-rich secretion used in prey capture and defense. In a typical model of venom evolution, gene duplicates switch to venom gland expression and ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97c6d09d1349b2827fdf92275849426e
https://doi.org/10.1093/gbe/evv253
https://doi.org/10.1093/gbe/evv253
Autor:
Damien C. Tully, Michael A. Cruz, Mauricio A. Martins, Rujuta Gadgil, Saverio Capuano, Diogo M. Magnani, David I. Watkins, Eva G. Rakasz, David J. Bean, Michael Piatak, Noemia S. Lima, Christopher L. Parks, Keisuke Ejima, Karen A. Power, David B. Allison, Jeffrey D. Lifson, Todd M. Allen, Ricardo Galler, John D. Altman, Marlon G. Veloso de Santana, Colin B. Ogilvie, Myrna C. Bonaldo
Publikováno v:
Journal of Virology. 89:10802-10820
Certain major histocompatibility complex class I (MHC-I) alleles (e.g., HLA-B*27 ) are enriched among human immunodeficiency virus type 1 (HIV-1)-infected individuals who suppress viremia without treatment (termed “elite controllers” [ECs]). Like
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6caa1d1136ee8e71ac8d0f8749877775
https://doi.org/10.1128/jvi.01440-15
https://doi.org/10.1128/jvi.01440-15
Autor:
Mauricio A. Martins, Nuria Pedreño-Lopez, Eva G. Rakasz, Martin J. Gutman, Michael Piatak, John D. Altman, Michael A. Cruz, David J. Bean, David I. Watkins, Keith A. Reimann, Rujuta Gadgil, Damien C. Tully, Young C. Shin, Helen S. Maxwell, Michael J. Ricciardi, Todd M. Allen, Varian K. Bailey, Ronald C. Desrosiers, Diogo M. Magnani, Kim L. Weisgrau, Myrna C. Bonaldo, Saverio Capuano, Lucas Gonzalez-Nieto, Jeffrey D. Lifson, Aline Domingues, Noemia S. Lima
Effector memory T cell (TEM) responses display potent antiviral properties and have been linked to stringent control of simian immunodeficiency virus (SIV) replication. Since recurrent antigen stimulation drives the differentiation of CD8+ T cells to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9b1352468ddf16567fd0ab135cae982
Autor:
Alia Thawer, Emily K. Bergsland, Pamela L. Kunz, Kathleen Hornbacker, Linda Wu, Thorvardur R. Halfdanarson, Rujuta Gadgil, Virginia Kelly, Nitya Raj, Diane Lauren Reidy, Patrick W. McGarrah, David Chan, Simron Singh, Jennifer A. Chan, Julia Whitman
Publikováno v:
Journal of Clinical Oncology. 37:321-321
321 Background: G3 NENs are aggressive, and optimal systemic treatment is unclear. Temozolomide (TEM)-based regimens have been used to treat grade 1-2 NETs, but their efficacy in G3 NENs (Ki-67 > 20%) remains undetermined. Aims: To assess the clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1252ab6e4d4ab13e78cad0bfd518e17
https://doi.org/10.1200/jco.2019.37.4_suppl.321
https://doi.org/10.1200/jco.2019.37.4_suppl.321